Menu

Industry Briefs

A report on genetically engineered plants predicts that they will begin reaching the marketplace within five years, but when they do, high research and testing costs will allow only the largest companies to compete in the field. Gerald Campbell, a St. Louis biochemist and one of the authors of the report, says the big companies likely to benefit from the technology are Calgene, Du Pont, and Monsanto. Under a contract with Campbell Soup, Calgene is now engaged in field trials of a genetically en

Oct 16, 1989
The Scientist Staff

A report on genetically engineered plants predicts that they will begin reaching the marketplace within five years, but when they do, high research and testing costs will allow only the largest companies to compete in the field. Gerald Campbell, a St. Louis biochemist and one of the authors of the report, says the big companies likely to benefit from the technology are Calgene, Du Pont, and Monsanto. Under a contract with Campbell Soup, Calgene is now engaged in field trials of a genetically engineered tomato. Through nonexpression of a gene, Calgene researchers have altered the enzyme that causes the softening of ripe tomatoes, thus allowing the plant to spend more time on the vine before harvest. Other promising avenues of research include plants that manufacture their own pesticides and herbicides. Campbell, who wrote the report for Frost & Sullivan Inc., a New York-based market research firm, could not say how much of an impact genetically engineered plants will have on agriculture in the near future.

Biotech Data Resource

Two charts that sort out the many sources of commercial biotechnology information have been compiled by the North Carolina Biotechnology Center. The charts describe 24 computer databases and their vendors and are available from the center at no charge. One chart lists the producers, vendors, updating frequencies, costs, years of coverage, and scope of coverage of the 24 databases that have been most useful to the center’s Biotechnology Information Division. A “hits per topic” column allows users to determine how appropriate a specific database might be for their business or research needs.

The second chart recommends 13 vendors of business information data services. These are companies that access a number of databases for individual users with limited on-line experience. For example, 16 of the databases listed in the first chart can be reached through Western Union’s InfoMaster database and 21 through Dialog’s Business Connection.

Requests for free copies of the database charts should be directed to Dina Murray, information assistant, at the North Carolina Biotechnology Center, RO. Box 13547, Research Triangle Park, NC. 27709-3547; (919)541-9366.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.